Skip to main content
logo
/
Novavax, Inc. (NVAX)
NASDAQ: NVAX · Real-Time Price · USD
6.84
-0.26 (-3.66%)
At close: Jul 11, 2025, 4:00 PM
6.85
+0.01 (0.15%)
After-hours: Jul 11, 2025, 7:50 PM EDT

Novavax Revenue by Segment

Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022Sep 30, 2022Jun 30, 2022Mar 31, 2022Dec 31, 2021
Product
729.79M190.44M391.89M355.91M621.17M531.39M567.72M1.19B
Product Growth
17.49%-64.16%-30.97%-70.13%-35.42%-65.83%-55.20%85.87%
Licensing Royalties and Other
525.86M492.41M455.36M428.89M35.50M24.99M23.09M5.47M
Licensing Royalties and Other Growth
1,381.50%1,870.20%1,872.54%7,747.96%36.64%-43.18%-86.51%-97.43%
Grants
-----427.32M458.95M400.30M
Grants Growth
-----11.60%12.39%-8.41%

Revenue by Geography

Period Ending Mar 31, 2025Dec 31, 2024Sep 30, 2024Jun 30, 2024Mar 31, 2024Dec 31, 2023Sep 30, 2023Jun 30, 2023Mar 31, 2023Dec 31, 2022
North America
110.79M65.02M56.94M25.21M23.60M29.96M2.23M-
North America Growth
369.51%117.04%2,452.35%-----
Rest of World
76.94M31.92M33.62M30.55M296.06M233.07M-593.28M
Rest of World Growth
-74.01%-86.30%--94.85%-18.91%-56.59%--
Europe
10.94M93.27M301.33M300.16M301.51M268.36M-468.58M
Europe Growth
-96.37%-65.24%--35.94%-35.45%-67.41%--
Source: Business metrics provided by Main Street Data and sourced from official company press releases and documents.